Breast Cancer

Featured Article
Dr Alison Conlin Provides Breast Cancer Treatment Updates, Discusses Pandemic’s Surprisingly Minimal Impact on Cancer Care
Alison Conlin, MD, MPH, medical oncologist, explains how care for HER2+ breast cancer has changed over the last 2 to 4 years compared with other forms of breast cancer—highlighting the approval of four new drugs and indications—and says COVID-19 has impacted cancer care less than other disease…
Common Treatment Challenges Among Patients With Breast Cancer and How it Compares to Other Cancer Types
William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and…
Navigating Through Breast Cancer Care With the Entire Care Team and Addressing Medication Costs
Jairam Krishnamurthy, MD, FACP, assistant professor of medicine, University of Nebraska Medical Center, reviews what it is like to navigate through breast cancer care with the whole care team—…

Newsfeed

Dr Alison Conlin Provides Breast Cancer Treatment Updates, Discusses Pandemic’s Surprisingly Minimal Impact on Cancer Care
Common Treatment Challenges Among Patients With Breast Cancer and How it Compares to Other Cancer Types
Navigating Through Breast Cancer Care With the Entire Care Team and Addressing Medication Costs
Identifying Risk-Reducing Strategies for Breast Cancer and How Payers Can Address the Costs of Medications
What We Know So Far About the Impact of the COVID-19 Pandemic on the Diagnosis, Treatment, and Prevention of Breast Cancer: Part I
Examining Improved Survival, Response Rates Among Patients With Breast Cancer
Nonconforming Breast Cancer Treatment in Elderly Women May Not Worsen Outcomes
Study Finds Insurance-Based Disparities in Breast Cancer Trial Outcomes
View More

Insights

What We Know So Far About the Impact of the COVID-19 Pandemic on the Diagnosis, Treatment, and Prevention of Breast Cancer: Part I
In this two-part series, Yvette Terrie, BS Pharm, RPh, consultant pharmacist, discusses the impact the pandemic has had on diagnosis, treatment and screening of breast cancer, latest breakthroughs in therapies, and helping patients in their journey…
View More

Interactive Features

Dr Alison Conlin Provides Breast Cancer Treatment Updates, Discusses Pandemic’s Surprisingly Minimal Impact on Cancer Care
Alison Conlin, MD, MPH, medical oncologist, explains how care for HER2+ breast cancer has changed over the last 2 to 4 years compared with other forms of breast cancer—highlighting the approval of four new drugs and indications—and says COVID-19 has…
Common Treatment Challenges Among Patients With Breast Cancer and How it Compares to Other Cancer Types
William Rayford Gwin III, MD, medical oncologist, Seattle Cancer Care Alliance, breaks down some common challenges in treating breast cancer that make it unique compared to other types of cancer, and provides some risk reducing strategies for breast…
Navigating Through Breast Cancer Care With the Entire Care Team and Addressing Medication Costs
Jairam Krishnamurthy, MD, FACP, assistant professor of medicine, University of Nebraska Medical Center, reviews what it is like to navigate through breast cancer care with the whole care team—including the patient, pharmacists, other providers, and…
Identifying Risk-Reducing Strategies for Breast Cancer and How Payers Can Address the Costs of Medications
Victor G Vogel, MD, medical oncologist, Geisinger Health System, discusses a variety of risk reducing strategies for breast cancer, including why some are “overdue,” explains why there is a lack in the uptake of medications among patients despite…
View More
Back to Top